Boosted by Covance Acquisition, LabCorp Posts 48 Percent Revenue Growth in Q4

Feb 18, 2016

|

NEW YORK (GenomeWeb) – Laboratory Corporation of America today reported fourth quarter revenue growth of 48 percent driven by its acquisition of Covance.

The Burlington, North Carolina-based clinical testing services firm had revenues of $2.24 billion in Q4, up from $1.51 billion in the fourth quarter of 2014 and above the average Wall Street estimate of $2.22 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Got Into the Lab Machines

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Even Bigger

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Not Going to Pay

Science reports that a Dutch research funding agency is combating a ransomware attack.

Science Papers Present Haplotype-Resolved Genomes, MiRNA-Linked Complex Tied to Ribosomal Protein Production

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.

Featured White Papers

Congenica Enables Five Minute Diagnosis of Previously Unsolved Case

Congenica CNV Calling for Exomes Whitepaper

Congenica Splice Site Finder White Paper

Expediting an Accurate Diagnosis through Streamlined Clinical Workflows

Mar

11

Featured Webinar

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

In this session, the third in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified gene fusions that may or may not serve as druggable targets.

Mar

16

Featured Webinar

The Predictive Power of Poop: COVID-19 Wastewater Surveillance to Inform Public Health Decisions in Colorado

Wastewater based epidemiology (WBE) has been established as a viable, valuable, and cost-effective means to monitor infectious disease within a community.

Mar

17

Featured Webinar

Spatial Profiling of Metabolic Regulation in the Human Tumor Microenvironment Using Multiplexed Ion Beam Imaging

In this webinar, Felix J. Hartmann of Stanford University will describe an approach that characterizes the metabolic regulome of individual cells together with their phenotypic identity.

Mar

18

Featured Webinar

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Viruses mutate as they strive to thrive in response to selective pressures.

Menu

Boosted by Covance Acquisition, LabCorp Posts 48 Percent Revenue Growth in Q4

To read the full story....

Breaking News

Seqster, Medable Team on Data Integration for Clinical Trials

Azova Home Collection Kit Gets FDA EUA for Use With Fluidigm SARS-CoV-2 Test

Eurofins Scientific Posts 17 Percent Increase in FY2020 Revenues

OpGen Unyvero IVD Platform Nabs Chinese Regulatory Approval

Bio-Techne Obtains Reimbursement Contract With Humana for Exosome Diagnostics Prostate Biopsy Test

Hologic Acquires European MDx Firm Diagenode for Approximately $159M

The Scan

Got Into the Lab Machines

Even Bigger

Not Going to Pay

Science Papers Present Haplotype-Resolved Genomes, MiRNA-Linked Complex Tied to Ribosomal Protein Production

Featured White Papers

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

The Predictive Power of Poop: COVID-19 Wastewater Surveillance to Inform Public Health Decisions in Colorado

Spatial Profiling of Metabolic Regulation in the Human Tumor Microenvironment Using Multiplexed Ion Beam Imaging

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

What's Popular?

Luminex Shares Surge on Rumor of Acquisition by DiaSorin

Hologic Acquires European MDx Firm Diagenode for Approximately $159M

ACMG Lobbying State Legislatures on Genetic Counselors' Scope of Practice Draws Criticism

Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year

Novacyt Obtains CE Mark for Extraction-Free COVID-19 PCR Test

Sponsorships